Brief: Oramed And Lifeward Announce Strategic Transaction
13/01/2026 12:59
Jan 13 (Reuters) - Lifeward Ltd 2RW.MU: ORAMED AND LIFEWARD ANNOUNCE STRATEGIC TRANSACTION ORAMED PHARMACEUTICALS INC - TO RECEIVE 49.9% OWNERSHIP IN LIFEWARD ORAMED PHARMACEUTICALS INC - MARK GRANT TO LEAD COMBINED PLATFORMS ORAMED PHARMACEUTICALS INC - LIFEWARD TO ISSUE $10 MILLION CONVERTIBLE NOTES ORAMED PHARMACEUTICALS INC - WILL RECEIVE 4% ON NET SALES OF REWALK FRANCHISE FOR UP TO 10 YEARS Source text: ID:nPnwV5H2a Further company coverage: 2RW.MU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results